SHELBY CALLOWAY: Open Payments
NPI 1295272714 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,731 in 170 payments from 37 companies in 2025. Trend: 2023 $2,786 · 2024 $4,185 · 2025 $3,731
Food & beverage: $3,731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $509 |
| UCB, Inc. | 17 | $357 |
| TG Therapeutics, Inc. | 6 | $260 |
| Biogen, Inc. | 10 | $197 |
| Lundbeck LLC | 10 | $184 |
| Lilly USA, LLC | 5 | $176 |
| Novartis Pharmaceuticals Corporation | 9 | $153 |
| Neurelis, Inc. | 6 | $150 |
| PFIZER INC. | 6 | $135 |
| Averitas Pharma Inc. | 5 | $124 |
Products named: BRIUMVI, BOTOX, KISUNLA, UBRELVY, KESIMPTA, VALTOCO, LEQEMBI, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
